AAP
MDLN

Arax Advisory Partners’s Medline Inc MDLN Stock Holding History

Arax Advisory Partners’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
5,882
+5,871
+53,373% +$237K ﹤0.01% 2149
2026
Q1 		$490 Hold
11
– – ﹤0.01% 3413
2025
Q4 		$462 Buy
+11
New +$465 ﹤0.01% 3623

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Arax Advisory Partners's MDLN Position: Q2 2026 in Review

Arax Advisory Partners increased its Medline Inc (MDLN) stake by 53,373% in Q2 2026, buying an estimated $237K and bringing the position to 5,882 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

Arax Advisory Partners first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Arax Advisory Partners held 5,882 shares of Medline Inc worth $232K as of Q2 2026.
  • Arax Advisory Partners bought 5,871 Medline Inc shares in Q2 2026, an estimated $237K.
  • Medline Inc made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2149 holding.
  • Arax Advisory Partners first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.